NARCAN

Serial Number 88863752
Registration 7231090
700

Registration Progress

Application Filed
Apr 8, 2020
Under Examination
Sep 29, 2020
Approved for Publication
Aug 4, 2020
Published for Opposition
Aug 4, 2020
Registered
Nov 28, 2023

Trademark Image

NARCAN

Basic Information

Serial Number
88863752
Registration Number
7231090
Filing Date
April 8, 2020
Registration Date
November 28, 2023
Published for Opposition
August 4, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 28, 2023
Registration
Registered
Classes
044

Rights Holder

EMERGENT OPERATIONS IRELAND LIMITED

77
Address
6 EARLSFORT TERRACE
6TH FLOOR
DUBLIN 2
IE

Ownership History

Adapt Pharma Operations Limited

Original Applicant
16
Dublin 2 IE

Adapt Pharma Operations Limited

Owner at Publication
16
Dublin 2 IE

EMERGENT OPERATIONS IRELAND LIMITED

New Owner After Publication #1
77
DUBLIN IE

EMERGENT OPERATIONS IRELAND LIMITED

Original Registrant
77
DUBLIN IE

Legal Representation

Attorney
Virginia Wolk Marino

USPTO Deadlines

Next Deadline
1404 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231128)
Due Date
November 28, 2029
Grace Period Ends
May 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Oct 2, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 18, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 28, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 28, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 25, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 24, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 2, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 28, 2023 IUAF S USE AMENDMENT FILED Loading...
Sep 28, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 22, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 9, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 21, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 9, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 14, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 11, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 9, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 9, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 9, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 27, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 4, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 4, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 15, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 26, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 16, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 11, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists
First Use Anywhere: Feb 1, 2016
First Use in Commerce: Feb 1, 2016

Classification

International Classes
044